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ABSTRACT 
Rapid developments in the field of molecular biology and gene technology resulted in generation of many macromolecular drugs including 
peptides, proteins, polysaccharides and nucleic acids in great number possessing superior pharmacological efficacy with site specificity and devoid 
of untoward and toxic effects. However, the main impediment for the oral delivery of these drugs as potential therapeutic agents is their 
extensive presystemic metabolism, instability in acidic environment resulting into inadequate and erratic oral absorption. Parentral route of 
administration is the only established route that overcomes all these drawbacks associated with these orally less/inefficient drugs. But, these 
formulations are costly, have least patient compliance, require repeated administration, in addition to the other hazardous effects associated  
with this route. Over the last few decades' pharmaceutical scientists throughout the world are trying to explore transdermal and transmucosal 
routes as an alternative to injections. Among the various transmucosal sites available, mucosa of the buccal cavity was found to be the most 
convenient and easily accessible site for the delivery of therapeutic agents for both local and systemic delivery as retentive dosage forms, 
because it has expanse of smooth muscle which is relatively immobile, abundant vascularization, rapid recovery time after exposure to stress 
and the near absence of langerhans cells. Direct access to the systemic circulation through the internal jugular vein bypasses drugs from the 
hepatic first pass metabolism leading to high bioavailability. Further, these dosage forms are self-administrable, cheap and have superior patient 
compliance. Developing a dosage form with the optimum pharmacokinetics is a promising area for continued research as it is enormously 
important and intellectually challenging. With the right dosage form design, local environment of the mucosa can be controlled and manipulated 
in order to optimize the rate of drug dissolution and permeation. A rational approach to dosage form design requires a complete understan ding 
of the physicochemical and biopharmaceutical properties of the drug and excipients. Advances in experimental and computationa l 
methodologies will be helpful in shortening the processing time from formulation design to clinical use. This paper aims to review the 
developments in the buccal adhesive drug delivery systems to provide basic principles to the young scientists, which will be useful to 
circumvent the difficulties associated with the formulation design. 
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I. INTRODUCTION 
The main impediment to the use of many hydrophilic macro- 
molecular drugs as potential therapeutic agents is their 
inadequate and erratic oral absorption. The relatively recent 
evolution of recombinant DNA research and modern 
synthetic and biotech- nological methodologies allow the 
biochemist and chemist to produce vast quantities of variety 
of peptides and proteins possessing better pharmacological 
efficacy. However, therapeutic potential of these compounds 
lies in our ability to design and achieve effective and stable 
delivery systems. The future challenge of pharmaceutical 
scientists will not only be polypeptide cloning and synthesis, 
but also to develop effective non parenteral delivery of intact 
proteins and peptides to the systemic circulation. Based on our 
current understanding of biochemical and physiological 
aspects of absorption and metabolism of many bio- 
technologically-produced drugs, they cannot be delivered 
effectively through the conventional oral route. Because after 
oral administration many drugs are subjected to 
presystemic clearance extensive in liver, which often leads to 
a lack of significant correlation between membrane 
permeability, absorption, and bioavailability 1. Difficulties 
associated with parenteral delivery and poor oral availability 
provided the impetus for exploring alternative routes for the 
delivery of such drugs. These include routes such as 
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pulmonary, ocular, nasal, rectal, buccal, sublingual, vaginal, 
and transdermal. In absence of external stimuli to facilitate 
absorption, use of these alternative routes has had limited 
success. Various strategies have been implemented to 
promote the bioavailability of these drugs, including 
supplemental administration of enzyme inhibitors, use of 
absorption enhancers, novel formulation strategies, and 
reversible chemical modifications 2. 
Among the various transmucosal routes, buccal mucosa has 
excellent accessibility, an expanse of smooth muscle and 
relatively immobile mucosa, hence suitable for administration 
of retentive dosage forms. Direct access to the systemic 
circulation through the internal jugular vein bypasses drugs 
from the hepatic first pass metabolism leading to high 
bioavailability. Other advantages such  as low enzymatic 
activity, suitability for drugs or excipients that mildly and 
reversibly damages or irritates the mucosa, painless 
administration, easy drug withdrawal, facility to include 
permeation enhancer/enzyme inhibitor or pH modifier in the 
formulation and versatility in designing as multidirectional or 
unidirectional release systems for local or systemic actions etc, 
opts buccal adhesive drug delivery systems as promising option 
for continued research 3 . 
Buccal mucosal structure and its suitability 
Buccal region is that part of the mouth bounded anteriorly and 
laterally by the lips and the cheeks, posteriorly and medially 
by the teeth and/or gums, and above and below by the 
reflections of the mucosa from the lips and cheeks to the 
gums. Numerous racemose, mucous, or serous glands are 
present in the sub mucous tissue of the cheeks 4. The buccal 
glands are placed between the mucous membrane and 
buccinator muscle: they are similar in structure to the labial 
glands, but smaller. About five, of a larger size than the rest, are 
placed between the masseter and buccinator muscles around 
the distal extremity of the parotid duct; their ducts open in the 
mouth opposite the last molar tooth. They are called molar 
glands 5 . Maxillary artery supplies blood to buccal mucosa 
and blood flow is faster and richer (2.4 ml/min/cm2) than that in 
the sublingual, gingival and palatal regions, thus facilitates 
passive diffusion of drug molecules across the mucosa. The 
thickness of the buccal mucosa is measured to be 500–800 
μm and is rough textured, hence suitable for retentive 
delivery sys- terms 6 . The turnover time for the buccal 
epithelium has been estimated at 5–6 days 7. Buccal mucosa 
composed of several layers of different cells as shown in Fig. 1. 
The epithelium is similar to stratified squamous epithelia found 
in rest of the body and is about 40–50 cell layers thick 5. Lining 
epithelium of buccal mucosa is the nonkeratinized stratified 
squamous epithelium that has thickness of approximately 500–
600 μ and surface area of 50.2 cm2. Basement membrane, 
lamina propria followed by the submucosa is present below 
the epithelial layer 8. Lamina propria is rich with blood vessels 
and capillaries that open to the internal jugular vein. Lipid 
analysis of buccal tissues shows the presence of phospholipid 
76.3%, glu- cosphingolipid 23.0% and ceramide NS at 0.72%. 
Other lipids such as acyl glucosylated ceramide, and ceramides 
like Cer AH, Cer AP, Cer NH, Cer AS, and EOHP/NP are completely 
absent 9. The primary function of buccal epithelium is the 
protection of the underlying tissue. In nonkeratinized 
regions, lipid-based permeability barriers in the outer 
epithelial layers protect the underlying tissues against fluid 
loss and entry of potentially harmful environmental agents 
such as antigens, carcinogens, microbial toxins and enzymes 
from foods and beverages 10. 
 
Figure 1 Cross-section of buccal mucosa 
Absorption pathways 
Studies with microscopically visible tracers such as small 
proteins 11 and dextrans 12 suggest that the major pathway 
across stratified epithelium of large molecules is via inter- 
cellular spaces and that there is a barrier to penetration as a result 
of modifications to the intercellular substance in the superficial 
layers. However, rate of penetration varies depending on the 
physicochemical properties of the molecule and the type of 
tissue being traversed. This has led to the suggestion that 
materials uses one or more of the following routes 
simultaneously to cross the barrier region in the process of 
absorption, but one route is pre- dominant over the other 
depending on the physicochemical pro- perties of the diffusant 
13. 
Passive diffusion 
Transcellular or intracellular route (crossing the cell 
membrane and entering the cell) 
Paracellular or intercellular route (passing between the 
cells) 
Carrier mediated transport 
Endocytosis 
The flux of drug through the membrane under sink condition 
for paracellular route can be written as Eq. (1) 
--------------------------(1) 
Where, Dp is diffusion coefficient of the permeate in the inter- 
cellular spaces, hp is the path length of the paracellular route, ε is 
the area fraction of the paracellular route and Cd is the donor 
drug concentration. Similarly, flux of drug through the 
membrane under sink condition for transcellular route can 
be written as Eq. (2). 
-------------------------(2) 
Where, Kc is partition coefficient between lipophilic cell 
mem- brane and the aqueous phase, Dc is the diffusion 
coefficient of the drug in the transcellular spaces and hc is the 
path length of the transcellular route 14. 
In very few cases absorption also takes place by the process of 
endocytosis where the drug molecules were engulfed by the 
cells. It is unlikely that active transport processes operate 
within the oral mucosa; however, it is believed that acidic 
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stimulation of the salivary glands, with the accompanying 
vasodilatation, faci- litates absorption and uptake into the 
circulatory system15. 
The absorption potential of the buccal mucosa is influenced by 
the lipid solubility and molecular weight of the diffusant. Ab- 
sorption of some drugs via the buccal mucosa is found to 
increase when carrier pH is lowered and decreased with an 
increase of pH 16 . However, the pH dependency that is evident in 
absorption of ionizable compounds reflects their partitioning 
into the epithelial cell membrane, so it is likely that such 
compounds will tend to penetrate transcellularly 17. Weak acids 
and weak bases are subjected to pH-dependent ionization. It is 
presumed that ionized species penetrate poorly through the 
oral mucosa compared with non-ionized species. An increase in 
the amount of non-ionized drug is likely to increase the 
permeability of the drug across an epithelial barrier, and this 
may be achieved by a change of pH of the drug delivery system. It 
has been reported that pH has effect on the buccal permeation of 
drug through oral mucosa 18 . The diffusion of drugs across buccal 
mucosa was not related to their degree of ionization as 
calculated from the Henderson–Hasselbalch equation and thus it 
is not helpful in the prediction of membrane diffusion of weak 
acidic and basic drugs 19 . 
In general, for peptide drugs, permeation across the buccal 
epithelium is thought to be through paracellular route by 
passive diffusion. Recently, it was reported that drugs that have 
a mono- carboxylic acid residue could be delivered into systemic 
circulation from the oral mucosa via its carrier 20 . The 
permeability of oral mucosa and the efficacy of penetration 
enhancers have been inves- tigated in numerous in vivo and in 
vitro models. Various kinds of diffusion cells, including 
continuous flow perfusion chambers, Ussing chambers, Franz 
cells and Grass–Sweetana, have been used to determine the 
permeability of oral mucosa 21. Cultured epi- thelial cell lines 
have also been developed as an in vitro model for studying drug 
transport and metabolism at biological barriers as well as to 
elucidate the possible mechanisms of action of pene- tration 
enhancers 22-23. Recently, TR146 cell culture model was 
suggested as a valuable in vitro model of human buccal mucosa 
for permeability and metabolism studies with enzymatically 
labile drugs, such as leu-enkefalin, intended for buccal drug 
delivery 24 . 
Barriers to penetration across buccal mucosa  
The barriers such as saliva, mucus, membrane coating granules, 
basement membrane etc retard the rate and extent of drug ab- 
sorption through the buccal mucosa. The main penetration 
barrier exists in the outermost quarter to one third of the 
epithelium 8. 
Membrane coating granules or cored granules 
In nonkeratinized epithelia, the accumulation of lipids and 
cytokeratins in the keratinocytes is less evident and the change 
in morphology is far less marked than in keratinized epithelia. 
The mature cells in the outer portion of nonkeratinized 
epithelia become large and flat retain nuclei and other 
organelles and the cytokeratins do not aggregate to form 
bundles of filaments as seen in keratinizing epithelia. As cells 
reach the upper third to quarter of the epithelium, membrane-
coating granules become evident at the superficial aspect of the 
cells and appear to fuse with the plasma membrane so as to 
extrude their contents into the intercellular space. The 
membrane-coating granules found in nonkeratinizing epithelia 
are spherical in shape, membrane-bounded and measure about 
0.2 μm in diameter 25. Such granules have been observed in a 
variety of other human nonkeratinized epithelia, including 
uterine cervix 26 and esophagus 27. However, current studies 
employing ruthenium tetroxide as a post-fixative indicate that 
in addition to cored granules, a small proportion of the 
granules in nonkeratinized epithelium do contain lamellae, 
which may be the source of short stacks of lamellar lipid 
scattered throughout the intercellular spaces in the outer 
portion of the epithelium. In contrast to the intercellular spaces 
of stratum corneum, those of the superficial layer of 
nonkeratinizing epithelia contain electron lucent material, 
which may represent nonlamellar phase lipid, with only 
occasional short stacks of lipid lamellae. 
Basement membrane 
Although the superficial layers of the oral epithelium represent 
the primary barrier to the entry of substances from the exterior, it 
is evident that the basement membrane also plays a role in limiting 
the passage of materials across the junction between epithelium 
and connective tissue. A similar mechanism appears to operate 
in the opposite direction. The charge on the constituents of the 
basal lamina may limit the rate of penetration of lipophilic 
compounds that can traverse the superficial epithelial barrier 
relatively easily 28. 
Mucus 
The epithelial cells of buccal mucosa are surrounded by the 
intercellular ground substance called mucus with the thickness 
varies from 40 μm to 300 μm29. Though the sublingual glands 
and minor salivary glands contribute only about 10% of all 
saliva, together they produce the majority of mucus and are 
critical in maintaining the mucin layer over the oral mucosa30. It 
serves as an effective delivery vehicle by acting as a lubricant 
allowing cells to move relative to one another and is believed to 
play a major role in adhesion of mucoadhesive drug delivery 
systems 31. At buccal pH, mucus can form a strongly cohesive gel 
structure that binds to the epithelial cell surface as a gelatinous 
layer 8 .Mucus mole- cules are able to join together to make 
polymers or an extended three-dimensional network. Different 
types of mucus are produced, for example G, L, S, P and F mucus, 
which form different network of gels. Other substances such as 
ions, protein chains, and enzymes are also able to modify the 
interaction of the mucus molecules and, as a consequence, their 
biophysical properties 32. 
Mucus is composed chiefly of mucins and inorganic salts 
suspended in water. Mucins are a family of large, heavily 
glycosylated proteins composed of oligosaccharide chains 
attached to a protein core. Three quarters of the protein core 
are heavily glycosylated and impart a gel like characteristic to 
mucus. Mucins contain approximately 70–80% carbohydrate, 
12–25% protein and up to 5% ester sulphate 33. The dense 
sugar coating of mucins gives them considerable water-
holding capacity and also makes them resistant to proteolysis, 
which may be important in maintaining mucosal barriers 4. 
Mucins are secreted as massive aggregates by prostaglandins 
with molecular masses of roughly 1 to 10 million Da. Within 
these aggregates, monomers are linked to one another mostly 
by non- covalent interactions, although intermolecular 
disulphide bonds also play a role in this process. 
Oligosaccharide side chains con- tain an average of about 8–
10 monosaccharide residues of five different types namely L-
fucose, D-galactose, N-acetyl-D-glucos- amine, N-acetyl-D-
galactosamine and sialic acid. Amino acids present are serine, 
threonine and proline 34. Because of the presence of sialic 
acids and ester sulfates, mucus is negatively charged at 
physiological salivary pH of 5.8–7.4 8. 
At least 19 human mucin genes have been distinguished by 
cDNA cloning-MUC1, 2, 3A, 3B, 4,5AC, 5B, 6–9, 11–13, and 15–
19. Mucin genes encode mucin monomers that are synthesized as 
rod-shaped apomucin covers that are post translationally modi- 
fied by exceptionally abundant glycosylation. Two distinctly dif- 
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ferent regions are found in mature genes. The amino- and 
carboxy- terminal regions are very lightly glycosylated, but rich in 
cysteines, which are likely, involved in establishing disulfide 
linkages within and among mucin monomers. A large central 
region formed of multiple tandems repeats of 10 to 80 residue 
sequences in which up to half of the amino acids are serine or 
threonine. This area becomes saturated with hundreds of O-
linked oligosaccharides also found on mucins, but much less 
abundantly 4. 
Mucins are characterized not only by large molecular masses 
but also by large molecular mass distributions, as seen by 
analytical ultra-centrifugation, and by the powerful technique 
of size exclusion chromatography coupled to multi-angle laser 
light sca- ttering35-36. In solution, mucins adopt a random-coil 
conformation occupying a time averaged spheroidal domain as 
shown by hydrodynamics and critical-point-drying37. Electron 
mi- croscopy. Mucins, which are different, are the submaxillary 
mu- cins, with a lower carbohydrate content and different 
structure 38. 
Saliva 
The mucosal surface has a salivary coating estimated to be   70 
μm thick39, which act as unstirred layer. Within the saliva there 
is a high molecular weight mucin named MG1 40   that can bind to 
the surface of the oral mucosa so as to maintain hydration, 
provide lubrication, concentrate protective molecules such as 
secretory immunoglobulins, and limit the attachment of micro- 
organisms. Several independent lines of evidence suggest that 
saliva and salivary mucin contribute to the barrier properties of 
oral mucosa 41. The major salivary glands consist of lobules of 
cells that secrete saliva; parotids through salivary ducts near the 
upper teeth, submandibular under the tongue, and the sublingual 
through many ducts in the floor of the mouth. Besides these 
glands, there are 600–1000 tiny glands called minor salivary 
glands located in the lips, inner cheek area (buccal mucosa), and 
extensively in other linings of the mouth and throat 42. Total 
output from the major and minor salivary glands is termed as 
whole saliva, which at normal conditions has flow rate of 1–2 
ml/min43. Greater salivary output avoids potential harm to acid-
sensitive tooth enamel by bathing the mouth in copious 
neutralizing fluid 44. With stimulation of salivary secretion, 
oxygen is consumed and vasodilator substances are produced; 
and the glandular blood flow increases, due to increased 
glandular metabolism 45. Saliva is composed of 99.5% water in 
addition to proteins, glycoproteins and electrolytes. It is high in 
potassium (7 × plasma), bicarbonate (3 × plasma), calcium, 
phosphorous, chloride, thiocyanate and urea and low in sodium 
(1/10 × plasma). The normal pH of saliva is 5.6-7. Saliva contains 
enzymes namely α-amylase (breaks 1–4 glycosidic bonds), 
lysozyme (protective, digests bacterial cell walls) and lingual 
lipase (break down the fats) 46. 
Saliva serves multiple important functions. It moistens the 
mouth, initiates digestion and protects the teeth from decay. It 
also controls bacterial flora of the oral cavity. Because saliva is 
high in calcium and phosphate, it plays a role in mineralization 
of new teeth repair and precarious enamel lesions. It protects 
the teeth by forming “protective pellicle”. This signifies a saliva 
protein coat on the teeth, which contains antibacterial 
compounds. Thus, problems with the salivary glands generally 
result in rampant dental caries. Lysozyme, secretory IgA, and 
salivary peroxidase play important roles in saliva's antibacterial 
actions. Lysozyme agglutinates bacteria and activates autolysins. 
Ig A interferes with the adherence of microorganisms to host 
tissue. Peroxidase breaks down salivary thiocyanate, which in 
turn, oxidizes the enzymes involved in bacterial glycolysis. 
However, salivary flow rate may play role in oral hygiene. 
Intraoral complications of salivary hypofunction may cause 
candidiasis, oral lichen planus, burning mouth syndrome, 
recurrent aphthous ulcers and dental caries. A constant flowing 
down of saliva within the oral cavity makes it very difficult for 
drugs to be retained for a significant amount of time in order to 
facilitate absorption in this site 44.  The other important factor of 
great concern is the role of saliva in development of dental 
caries. Salivary enzymes act on natural polysaccharidic 
polymers that hasten the growth of mutants of streptococci and 
other plaque bacteria leading to development of dental caries. 
In general, intercellular spaces pose as the major barrier to 
permeation of lipophilic compounds, and the cell membrane 
which is lipophilic in nature acts as the major transport barrier 
for hydrophilic compounds because it is difficult to permeate 
through the cell membrane due to a low partition coefficient 
45. Permeability between different regions of the oral cavity 
vary greatly because of the diverse structures and functions. In 
general, the permeability is based on the relative thickness 
and degree of keratinization of these tissues in the order of 
sublingual> buccal> palatal. The permeability of the buccal 
mucosa was estimated to be 4–4000 times greater than that 
of the skin46. 
II. FORMULATION DESIGN 
Buccal adhesive drug delivery systems with the size 1–3 cm2 
and a daily dose of 25 mg or less are preferable. The maximal 
duration of buccal delivery is approximately 4–6 h 47. 
Pharmaceutical considerations 
Great care needs to be exercised while developing a safe and 
effective buccal adhesive drug delivery device. Factors 
influencing drug release and penetration through buccal 
mucosa, organoleptic factors, and  effects  of  additives used 
to improve drug release pattern and absorption, the effects 
of local drug irritation caused at the site of application are to 
be considered while designing a formulation48. 
Buccal adhesive polymers  
Polymer is a generic term used to describe a very long 
molecule consisting of structural units and repeating units 
connected by covalent chemical bonds. The term is derived 
from the Greek words: polys meaning many, and meros 
meaning parts49. The key feature that distinguishes 
polymers from other molecules is the repetition of many 
identical, similar, or complementary molecular subunits in 
these chains. These subunits, the monomers, are small 
molecules of low to moderate molecular weight, and are 
linked to each other during a chemical reaction called 
polymerization. Instead of being identical, similar monomers 
can have varying chemical substituents. The differences 
between monomers can affect properties such as solubility, 
flexibility, and strength. The term buccal adhesive polymer 
covers a large, diverse group of molecules, including 
substances from natural origin to biodegradable grafted co- 
polymers and thiolated polymers50. 
Bioadhesive formulations use polymers as the adhesive 
component. These formulations are often water soluble and 
when in a dry form attract water from the biological surface 
and this water transfer leads to a strong interaction. These 
polymers also form viscous liquids when hydrated with 
water that increases their retention time over mucosal 
surfaces and may lead to adhesive interactions. Bioadhesive 
polymers should possess certain physicochemical features 
including hydrophilicity, numerous hydrogen bond-forming 
groups, flexibility for interpenetration with mucus and 
epithelial tissue, and viscoelastic properties51. 
Ideal characteristics 52 
Should demonstrate acceptable shelf life. 
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Should have optimum molecular weight. 
Should possess adhesively active groups. 
Should have required spatial conformation. 
Should be sufficiently cross-linked but not to the degree of 
suppression of bond forming groups. 
Should not aid in development of secondary infections such 
as dental caries. 
Polymer and its degradation products should be non-toxic, 
non-irritant and free from leachable impurities. 
Should have good spreadability, wetting, swelling and 
solubility and biodegradability properties. 
pH should be biocompatible and should possess good 
viscoelastic properties. 
Should adhere quickly to buccal mucosa and should possess 
sufficient mechanical strength. 
Should possess peel, tensile and shear strengths at the 
bioadhesive range. 
Polymer must be easily available and its cost should not be 
high. 
Should show bioadhesive properties in both dry and liquid 
state. 
Should demonstrate local enzyme inhibition and penetra- 
tion enhancement properties. 
Some representative polymers  
Hydrogels. Hydrogels, often called as “wet” adhesives 
because they require moisture to exhibit the adhesive 
property. They are usually considered to be cross linked 
water swollen polymers having water content ranging from 
30% to 40% depending on the polymer used. These are 
hydrophilic matrices that absorb water when placed in an 
aqueous media. This may be supplied by the saliva, which 
may also act as the dissolution medium. They are structured 
in such a manner that the crosslinking fibers present in their 
matrix effectively prevent them from being dissolved and 
thus help them in retaining water. When drugs are loaded 
into these hydrogels, as water is absorbed into the matrix, 
chain relaxation occurs and drug molecules are released 
through the spaces or channels within the hydrogel network. 
Polymers such as polyacrylates (carbopol and 
polycarbophil), ethylene vinyl alcohol, polyethylene oxide, 
poly vinyl alcohol, poly (N-acryloylpyrrolidine), 
polyoxyethylenes, self-cross linked gelatin, sodium alginate, 
natural gums like guar gum, karaya gum, xanthan gum, locust 
bean gum and cellulose ethers like methyl cellulose, 
hydroxypropyl cellulose, hydroxyl propyl methyl cellulose, 
sodium carboxy methyl cellulose etc. form part of the family 
of hydrogels 53. 
Copolymers  
Researchers are currently working on carrier systems 
containing block copolymers rather than using single 
polymeric system. Copolymerization with two or more 
different monomers results in chains with varied 
properties. A block copolymer is formed when the reaction is 
carried out in a stepwise manner, leading to a structure with 
long sequences or blocks of one monomer alternating with 
long sequences of the other. These networks when composed 
of hydrophilic and hydrophobic monomers are called 
polymer micelle. These micelles are suitable for enclosing 
individual drug molecules. Their hydrophilic outer shells 
help to protect the cores and their contents from chemical 
attack by aqueous medium. Most micelle-based systems are 
formed from poly (ethylene oxide)-b-polypropylene-b-poly 
(ethylene oxide) tri- block network. There are also graft 
copolymers, in which entire chains of one kind (e.g., 
polystyrene) are made to grow out of the sides of chains of 
another kind (e.g., polybutadiene), resulting in a product that 
is less brittle and more impact-resistant. Thus, block and graft 
copolymers can combine the useful properties of both 
constituents and often behave as quasi-two-phase systems 54. 
Multifunctional polymers 
These are the bioadhesive polymers having multiple 
functions. In addition to the possession of bioadhesive 
properties, these polymers will also serve several other 
functions such as enzyme inhibition, permeation enhancing 
effect etc. Examples are polyacrylates, po- lycarbophil, 
chitosan etc.55. 
Thiolated polymers 
These are the special class of multifunctional polymers also 
called thiomers. These are hydrophilic macromolecules 
exhibiting free thiol groups on the polymeric backbone. Due 
to these functional groups various features of well-
established polymeric excipients such as poly (acrylic acid) 
and chitosan were strongly improved. Thiolated polymers 
designated thiomers are capable of forming disulphide bonds 
with cysteine-rich subdomains of mucus glycoproteins 
covering mucosal membranes. Consequently, the bridging 
structure most commonly used in biological systems is 
utilized to bind drug delivery systems on the mucosal 
membranes. By immobilization of thiol groups the 
mucoadhesive properties of poly (acrylicacid) and chitosan, 
was improved to 100-fold to 250- fold 56. 
Thiomers are capable of forming intra- and inter-chain 
disulphide bonds within the polymeric network leading to 
strongly improved cohesive properties and stability of drug 
delivery systems such as matrix tablets. Due to the formation of 
strong covalent bonds with mucus glycoproteins, thiomers 
show the strongest mucoadhesive properties of all so far tested 
polymeric excipients via thioldisulphide exchange reaction and 
an oxidation process. Zinc dependent proteases such as 
aminopeptidases and carboxy peptidases are inhibited by 
thiomers. The underlying mechanism is based on the capability 
of thiomers to bind zinc ions and this property is highly 
beneficial for oral administration of protein and peptide drugs. 
They also exhibit permeation-enhancing effects for the 
paracellular uptake of drugs based on a glutathione-mediated 
opening process of the tight junctions 57. 
Milk protein  
A particular example is a milk protein concentrate containing 
a minimum of 85% of proteins such as Prosobel L85, LR85F 
at concentration of 15% to 50%, preferably 20% to 30% in a 
bioadhesive tablet showed good bioadhesive property 58. 
In general 
Cationic and anionic polymers bind more effectively than 
neutral polymers, Anionic polymers with sulphate groups 
bind more effectively than those with carboxylic groups, 
Polyanions are better than polycations in terms of binding 
potential and toxicity, Water-insoluble polymers give greater 
flexibility in dosage form design compared to rapidly or 
slowly dissolving water-soluble polymers, Degree of binding 
is proportional to the charge density on the polymer 59. 
Factors governing drug release from a polymer    
For a given drug the release kinetics from the polymer 
matrix could be governed predominantly by the polymer 
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morphology and excipients present in the system. Drug 
release from a polymeric material takes place either by the 
diffusion or by polymer degradation or by a combination of 
the both.  Polymer degradation generally takes place  by the 
enzymes  or hydrolysis either in the form of bulk erosion or 
surface erosion 60. 
Polymer morphology 
 The polymer matrix could be formulated as macro or 
nanospheres, gel film or an extruded shape (cylinder, rod 
etc). Also the shape of the extruded polymer can be 
important to the drug release kinetics. It has been shown that 
zero order release kinetics can be achieved using 
hemispherical polymer form 61 . 
Excipients 
The main objective of incorporating excipients in the 
polymer matrix is to modulate polymer degra- dation 
kinetics. Studies carried out have shown that by in- 
corporating basic salts as excipients slow down the 
degradation and increases the stability of protein polymers. 
Similarly hydro- philic excipients can accelerate the release 
of drugs although they may also increase the initial burst 
effect 62. 
Physiological considerations 
Physiological considerations such as texture of buccal 
mucosa, thickness of the mucus layer, its turn over time, 
effect of saliva and other environmental factors are to be 
considered in designing the dosage forms. Saliva contains 
moderate levels of esterases, carbohydrases, and 
phosphatases that may degrade certain drugs. Although 
saliva secretion facilitates the dissolution of drug, 
involuntary swallowing of saliva also affects its 
bioavailability. Hence development of unidirectional release 
systems with backing layer results high drug bioavail- ability 
63. 
Pharmacological considerations 
Drug absorption depends on the partition coefficient of the 
drugs. Generally lipophilic drugs absorb through the 
transcellular route, whereas hydrophilic drugs absorb 
through the paracellular route. Chemical modification may 
increase drug penetration through buccal mucosa. Increasing 
nonionized fraction of ionizable drugs increases drug 
penetration through transcellular route. In weakly basic 
drugs, the decrease in pH increases the ionic fraction of drug 
but decreases its permeability through buccal mucosa. 
Electrostatic interactions of drugs such as tetracycline, 
hydrogen bonding with drugs like urea and hydrophobic 
interactions with drugs like testosterone with mucin will 
decrease rate of absorption. Residence time and local 
concentration of the drug in the mucosa, the amount of drug 
transported across the  mucosa into the blood are the 
responsible factors for local or systemic drug delivery. 
Optimization by a suitable formula- tion design hastens drug 
release from the dosage form and taken up by the oral 
mucosa. Drugs such as buprenorphine, testosterone, 
fentanyl, nifedipine and several peptides such as insulin, 
thyrotropin-releasing hormone, and oxytocin have been tried 
to deliver via the buccal route. However the relative 
bioavailabilities of peptides by the buccal route were still low 
due to its poor permeation and enzymatic barrier of buccal 
mucosa but can be improved by the incorporation of 
penetration enhancers and/or enzyme inhibitors. Previous 
drug absorption studies have demonstrated that oral 
mucosal absorption of amines and acids at constant 
concentration are proportional to their partition coefficients. 
Similar dependencies on partition coefficients were obtained 
from acyclovir, β- adrenoreceptor blocking agents, 
substituted acetanilide, and others 64. 
Permeation enhancers 
Membrane permeation is the limiting factor for many drugs 
in the development of buccal adhesive delivery devices. The 
epithelium that lines the buccal mucosa is a very effective 
barrier to the absorption of drugs. Substances that facilitate 
the permeation through buccal mucosa are referred as 
permeation enhancers. As most of the penetration enhancers 
were originally designed for purposes other than 
absorption enhancement, a systemic search for safe and 
effective penetration enhancers must be a priority in drug 
delivery. The goal of designing penetration enhancers, with 
improved efficacy and reduced toxicity profile is possible by 
under- standing the relationship between enhancer structure 
and the effect induced in the membrane and of course, the 
mechanism of action. However, the selection of enhancer and 
its efficacy depends on the physicochemical properties of the 
drug, site of administration, nature of the vehicle and other 
excipients. In some cases usage of enhancers in combination 
has shown synergistic effect than the individual enhancers. 
The efficacy of enhancer in one site is not same in the other 
site because of differences in cellular morphology, 
membrane thickness, enzymatic activity, lipid composition 
and potential protein interactions are structural and 
functional properties. Penetration enhancement to the buccal 
membrane is drug specific. Effective penetration enhancers 
for transdermal or intestinal drug delivery may not have 
similar effects on buccal drug delivery because of structural 
differences; however, enhancers used to improve drug 
permeation in other absorptive mucosae improve drug 
penetration through buccal mucosa. These permeation 
enhancers should be safe and non-toxic, pharma- cologically 
and chemically inert, non-irritant, and nonaller- genic. 
However, examination of penetration route for transbuccal 
delivery is important because it is fundamental to select the 
proper penetration enhancer to improve the drug 
permeability. The different permeation enhancers available 
are 65. 
Chelators: EDTA, citric acid, sodium salicylate, methoxy 
salicylates. 
Surfactants: sodium lauryl sulphate, polyoxyethylene, 
Polyoxyethylene-9-laurylether, Polyoxythylene-20-cety- 
lether, Benzalkonium chloride, 23-lauryl ether, cetylpyr- 
idinium chloride, cetyltrimethyl ammonium bromide. 
Bile salts: sodium glycocholate, sodium deoxycholate, 
sodium taurocholate, sodium glycodeoxycholate, sodium 
taurodeoxycholate. 
Fatty acids: oleic acid, capric acid, lauric acid, lauric acid/ 
propylene glycol, methyloleate, lysophosphatidylcholine, 
phosphatidylcholine. 
Non-surfactants: unsaturated cyclic ureas. 
Inclusion complexes: cyclodextrins. 
Others: aprotinin, azone, cyclodextrin, dextran sulfate, 
menthol, polysorbate 80, sulfoxides and various alkyl 
glycosides. 
Thiolated polymers: chitosan-4-thiobutylamide, chitosan- 4-
thiobutylamide/GSH, chitosan-cysteine, Poly (acrylic acid)-
homocysteine, polycarbophil-cysteine, polycarbo- phil-
cysteine/GSH, chitosan-4-thioethylamide/GSH, chit- osan-4-
thioglycholic acid. 
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Mechanisms of action 
Mechanisms by which penetration enhancers are thought to 
improve mucosal absorption are as follows 66 
Changing mucus rheology: Mucus forms viscoelastic layer of 
varying thickness that affects drug absorption. Further, saliva 
covering the mucus layers also hinders the absorption. Some 
permeation enhancers' act by reducing the viscosity of the 
mucus and saliva overcomes this barrier. 
Increasing the fluidity of lipid bilayer membrane: The most 
accepted mechanism of drug absorption through buccal 
mucosa is intracellular route. Some enhancers disturb the 
intracellular lipid packing by interaction with either lipid 
packing by interaction with either lipid or protein 
components. 
Acting on the components at tight junctions: Some enhancers 
act on desmosomes, a major component at  the tight 
junctions there by increases drug absorption. By overcoming 
the enzymatic barrier: These act by inhibiting the various 
peptidases and proteases present within buccal mucosa, 
thereby overcoming the enzymatic barrier. In addition, 
changes in membrane fluidity also alter the enzymatic 
activity indirectly. 
Increasing the thermodynamic activity of drugs: Some 
enhancers increase the solubility of drug there by alters the 
partition coefficient. This leads to increased thermo- 
dynamic activity resulting better absorption. 
Surfactants such as anionic, cationic, nonionic and bile salts 
increases permeability of drugs by perturbation of 
intercellular lipids whereas chelators act by interfering with 
the calcium ions, fatty acids by increasing fluidity of 
phospholipids and positively charged polymers by ionic 
interaction with negative charge on the mucosal surface. 
Chitosan exhibits several favorable properties such as 
biodegradability, biocompatibility and 
antifungal/antimicrobial properties in addition to its 
potential bioadhesion and absorption enhancer. 
III. MUCO/BIOADHESION 
Bioadhesion is the phenomenon between two materials, 
which are held together for extended periods of time by 
interfacial forces. It is generally referred as bioadhesion 
when interaction occurs between polymer and epithelial 
surface; mucoadhesion when occurs with the mucus layer 
covering a tissue. Generally bioadhesion is deeper than the 
mucoadhesion. However, these two terms seem to be used 
interchangeably. It is interesting that the interaction between 
the layers adsorbed from whole saliva resembles the one 
previously reported between layers of adsorbed gastric 
mucins, which points to a strong contribution to the 
interaction of high molecular weight glycoproteins 67. 
Bio/mucoadhesive forces 
The common nature of all adhesive events, interfacial 
phenomena and forces that are involved in bioadhesion are 
strongly related to those considered in classical colloid and 
surface science. Intermolecular forces are electromagnetic 
forces which act between molecules or between widely 
separated regions of a macromolecule. These are fundamen- 
tally electrostatic interactions or electrodynamic 
interactions. Such forces may be either attractive or 
repulsive in nature. They are conveniently divided into two 
classes: short-range forces, which operate when the centers 
of the molecules are separated by 3 angstroms or less and 
long-range forces, which operate at greater distances. 
Generally, if molecules do not tend to interact chemically, the 
short-range forces between them are repulsive. These forces 
arise from interactions of the electrons associated with the 
molecules and are also known as exchange forces. Molecules 
that interact chemically have attractive exchange forces; these 
are also known as valence forces. Mechanical rigidity of 
molecules and effects such as limited compressibility of matter 
arise from repulsive exchange forces. Long-range forces, or 
van der Waal's forces as they are also called, are attractive 
and account for a wide range of physical phenomena, such as 
friction, surface tension, adhesion and cohesion of liquids 
and solids, viscosity, and the discrepancies between the 
actual behavior of gases and that predicted by the ideal gas 
law 68. 
Many theories have been proposed to explain the forces that 
underpin bioadhesion. They are: Electronic theory, 
Adsorption theory, Wetting theory, Diffusion theory and 
Fracture theory, etc.69.  
However, there is yet to be a clear explanation. As 
bioadhesion occurs between inherently different mucosal 
surfaces and formulations that are solid, semisolid and 
liquid, it is unlikely that a single, universal theory will 
account for all types of adhesion observed. In biological 
systems it must be recognized that, owing to the 
amphiphilicity of many biological macromolecules, 
orientation effects can often occur at inter- faces. These are 
crucially important and have in fact been reported to be so 
dramatic as to change overall long-range interactions from 
being purely repulsive to their becoming attractive. For any 
type of charged surface, such as biosurfaces, it is common to 
distinguish between pure electrostatic repulsive forces, 
which oppose adhesion, and attractive forces, which, if the 
surfaces come close enough, will strive to bring the interacting 
bodies together. This balanced relationship between 
repulsive and attractive interactions is expressed in the 
DLVO theory. In biological systems, interactions can be more 
complex, as they often take place in high ionic strength 
aqueous media and in the presence of macromolecules. 
Therefore electrostatic contributions may be less important, 
at least at long range, in favor of force components such as 
steric forces, hydrophobic interactions, and hydration forces 
70. 
Vander Waal's forces 
The attractive forces included in the DLVO theory are nor- 
mally termed van der Waal's forces and will arise in a number 
of ways. These may be further divided into the following 
three components 71: 
I. London dispersion forces: These are also called as dis- 
persion forces. These originate out of the electronic motions 
in paired molecules and give rise to attractive interactions. 
These forces involve the attraction between temporarily 
induced dipoles in nonpolar molecules (often disappear 
within a second). This polarization can be induced either by a 
polar molecule or by the repulsion of negatively charged 
electron clouds in nonpolar molecules. These results when 
two atoms belonging to different molecules are brought 
sufficiently close together. These interactions involve a force 
of about 0.5–1 K cal/mole. London Dispersion forces exist 
between all atoms. 
II. Dipole–dipole interactions: These are also called Keesom 
interactions after Willem Hendrik Keesom who produced the 
first mathematical description in 1921, are the forces that 
occur between two molecules with permanent dipoles. These 
work in a similar manner to ionic inter- actions, but are 
weaker because only partial charges are involved. These are 
due to attraction between polar groups. These have force of 
1–7 K cal/mole. Dipole– dipole interactions also come from 
partial charges another order of magnitude weaker. 
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III. Debye type forces: These are the interactions between 
permanent and induced dipoles. Permanent dipoles can 
induce a transient electric dipole in non-polar molecules and 
produce dipole induced dipole interactions. These 
interactions involve a force of about 1–3 K cal/mole. 
The non-retarded van der Waal's force is inversely pro- 
portional to the square of the distance between two spherical 
particles, where the proportionality constant is the Hamaker 
constant, which has the dimension of energy, can be used to 
describe the strength of the van der Waal's interaction and is 
dependent on the properties of the involved particles and on 
the medium where the interaction takes place 72. 
Hydrogen bonding 
Hydrogen bonding is basically an electrostatic interaction 
that arises when a hydrogen atom bound to an 
electronegative atom, e.g., nitrogen, oxygen, or fluorine, 
interacts with another electronegative atom. The result is a 
dipolar molecule. The hydrogen atom has a partial positive 
charge and hence can interact with another highly 
electronegative atom in an adjacent molecule. This results in 
a stabilizing interaction that binds the two molecules 
together. The force is short range and highly directional. In a 
more hydrophobic environment, hydrogen bonds become 
significant and are essential in the formation of stable 
structures. Bond energy serves as a measure of strength of 
bonds. Magnitude of bond energy for hydrogen bond is 
between 10 and 20 kJ/mol. Role of hydrogen bonding in 
interaction between mucoadhesive and mucin at gastric pH 
was studied by Tobyn et al. The bonding is stronger and is 
directional. The directional nature of hydrogen bonding 
requires the two molecules to adopt a specific relative 
geometry 73. 
Disulphide bridging  
A disulfide bond (SS-bond), also called a disulfide bridge, is a 
strong covalent bond between two sulfhydryl (–SH) groups. 
Oxidation of the thiol group yields a disulfide (S–S) bond. This 
bond is very important to the folding, structure, and function 
of proteins. Due to the formation of strong covalent bonds 
with mucus glycoproteins, thiomers show the strongest 
mucoadhesive properties of all so far tested polymeric 
excipients via thioldisulphide exchange reaction and an 
oxidation process as shown in Figure 2 74. 
Hydration forces 
A type of short-range (< 1 nm) repulsive interaction, 
suggested as originating from the binding of water molecules 
to polar surface sites, has been observed between 
phospholipids and solid surfaces under certain conditions. 
This hydration force is believed to be particularly important 
in biological systems, since it prevents contact even in the 
absence of charge–charge repulsion 75. 
Electrostatic double-layer forces 
A charged surface is always surrounded by a cloud of counter 
ions (double-layer), which balances the surface charge. 
When two surfaces with the same charge approach each 
other, a repulsive force will arise due to the overlap of the 
double layers. This is the origin of the electrostatic double-
layer forces, which can be described by the so-called 
Poisson–Bolzmann equation. These forces decay 
exponentially with the surface separation, with a decay 
length that decreases with increasing ionic strength in the 
surrounding medium. It should be noted that specific 
dispersion force-induced ion adsorption could some- times 
dominate at charged interfaces, thereby making it virtually 
impossible to distinguish between the contributions of 
electrostatic and dispersion forces. In biological fluids, which 
generally carry a large net negative charge, contribute 
significantly to the decay length already at low 
concentrations. Thus, the decay length in saliva is likely to be 
less than the value of approximately 1.0 nm calculated from 
its salt composition. Any increase in ionic strength, 
increases adhesion to negatively charged surfaces; this was 
assigned to less repulsion between the surface and the 
adhering cells 76. 
Hydrophobic interactions 
Hydrophobic effect is another particularly important 
phenomenon with respect to bioadhesion related to the 
presence of water. It is the property that nonpolar molecules 
like to self-associate in the presence of aqueous solution. It 
has been assigned to the tendency of water molecules to 
form ordered structures in proximity to non-polar molecular 
domains and may give rise to attractive interactions between 
non-polar residues such as hydrocarbon side chains. The 
hydrophobic effect is usually described in the context of 
protein folding, protein–protein interactions, nucleic acid 
structure, and protein–small molecule interactions. In the 
case of protein folding, it is used to explain why many 
proteins have a hydrophobic core which consists of 
hydrophobic amino acids, such as alanine, valine, leucine, 
isoleucine, phenylalanine, and methionine grouped together; 
often coiled-coil structures form around a central 
hydrophobic axis. The energetics of DNA tertiary structure 
assembly were determined by Eric Kool to be mostly caused by 
the hydrophobic effect, as opposed to Watson–Crick base 
pairing 77. 
The hydrophobic effect can be nullified to a certain extent by 
lowering the temperature of the solution to near zero degrees; 
at such temperatures, water prefers to be in an ordered 
structure and the order generated by hydrophobic patches is 
no longer as energetically unfavorable. This is neatly 
demonstrated by the increased solubility of benzene in water 
at temperatures lower than room temperature. On the 
macroscopic level, long-range attractive forces have been 
observed between hydrophobic surfaces formed by 
adsorption or deposition of amphiphilic molecules and are   
believed   to   be   non-equilibrium forces 78. 
 
 
Figure 2 Formation of covalent bonds between thiolated polymers and mucin glycoproteins 
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It should be noted that the origin of the long-range attractive 
forces between hydrophobic surfaces is controversial, but 
their occurrence has been related to instability of the 
deposited monolayer. Strength of these interactions is about 
0.37 kcal/mol 79. 
Steric forces 
Repulsive steric interactions or steric forces appear as the 
result of the increasing concentration of molecular segments 
that occurs when surfaces bearing for example bound macro- 
molecules come close to each other and therefore considered 
to be important in biological systems. The maximum possible 
number of molecular contacts between an adhesive and its 
substrate may be greatly restricted by the steric aspects of 
molecular geometry 80. 
Covalent bonds 
Like metallic bonds, covalent bonds are characterized by the 
electrons that are shared between the engaged atoms. 
Covalent bonds operate only over short interatomic 
distances (1– 2× 10− 1 nm). They tend to decrease in strength 
with increasing bond-length, and are oriented at well-defined 
angles. Unless chemical reactions take place, based on the 
formation or breakup of for example disulphide bridges, 
covalent bonds are unlikely to be important in bioadhesion 
processes under physiological conditions. On the basis of 
molecular interactions, the interaction between two molecules 
is composed of attraction and repulsion. Attractive interactions 
arise from weak forces such as van der Waal's forces, 
electrostatic attraction, hydrogen bonding, hydrophobic 
interac- tions and/or strong forces, which are covalent in nature. 
Repulsive interactions occur because of electrostatic and 
steric repulsion. For  muco/bioadhesion to occur,  the 
attractive interactions should be larger than nonspecific 
repulsion 81. 
Steps involved in the process of bio/mucoadhesion are 
i.Spreading, wetting, swelling and dissolution of bio/ 
mucoadhesive polymer at the interface, initiates intimate 
molecular contact at the interface between the polymer and 
the epithelial/mucus layer.  
Ii. Interdiffusion and interpenetration between the chains of 
the adhesive polymer and the mucus/epithelial surface 
resulting physical cross links or mechanical interlocking.  
Iii. Adsorption: The orientation of the polymers at the interface 
so that adhesive bonding across the interface is possible and 
Iv. Formation of secondary chemical bonds between the 
polymer chains and mucin molecules 82. 
Methods for measuring mucoadhesion 
These tests are important during the design and development 
of a mucoadhesive release system to study compatibility, 
stability, surface analysis and bioadhesive bond strength. 
These tests are broadly classified in to qualitative methods 
and quantitative methods 83. 
Quantitative methods 
These are also called macroscopic methods. The majority of the 
quantitative bio and/or mucoadhesion measurement methods 
found in the literature are based on measuring the force 
required to break the adhesive bond between the model 
membrane and the adhesive. Depending on the direction in 
which the adhesive is being separated from the substrate, peel, 
shear, and tensile forces can be measured 83.  
 
 
Determination of peel strength 
 The peel adhesion tests are mainly used for buccal and 
transdermal patches. The test is based on the calculation of 
energy required to detach the dosage form from the 
substrate material (usually excised buccal mucosa) attached 
through the bioadhesive material in the direction as shown in 
Figure 3. Fracture Energy (G) 
------------------(3) 
Where P is the peel force;w is the peel width; W° is the 
intrinsic work of adhesion and k is the proportionality constant 
that accounts for hysteretic losses. Peel work is the sum of 
the following components 84 
Surface energy that results from the creation of two free 
surfaces (energy of dewetting) also referred to as the 
intrinsic work of adhesion (or cohesion) 
Bulk energy that dissipates into the stripping member 
Strain energy in the newly detached strip 
Intrinsic work of adhesion (or cohesion) is independent of 
the following: 
Peel rate (speed), Peel angle, Thickness of the adhesive and 
Thickness of the stripping member 
 
Figure  3. Representation of peel, shear and tensile 
forces 
Determination of shear strength  
Shear stress, τ is  the force acting tangentially to a surface 
divided by the area of the surface. It is the force per unit area 
required to sustain a constant rate of fluid movement. 
Mathematically, shear stress can be defined as 85: s ¼ F=A 
Where, τ shear stress, force A and area of the surface 
subjected to the force. 
If a fluid is placed between two parallel plates spaced 1.0 cm 
apart, and a force of 1.0 dyn is applied to each square centimeter 
of the surface of the upper plate to keep it in motion, the shear 
stress in the fluid is 1 dyn/cm2 at any point between the two 
plates. Shear stress measures the force that requires 
causing the bioadhesive to slide with respect to the mucus 
layer in a direction parallel to their plane of contact as shown 
in Figure 3. 
Sam et al. studied the mucoadhesiveness of Ca polycarbophil, 
sodium CMC, HPMC using homogenized mucus from pig in- 
testine as model substrate by modified wilhelmy plate 
surface tension apparatus. Similarly, Smart et al. studied 
mucoadhesive strength of CP 934, Na CMC, HPMC, gelatin, PVP, 
acacia, PEG, pectin, tragacanth and sodium alginate was 
measured by the force required to pull the plate out of the 
solution is determined under constant experimental 
conditions by using mucus from guinea pig intestine as model 
substrate by Wilhelmy plate method, where a glass plate 
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suspended from a microbalance, which was dipped in a 
temperature-controlled mucus sample. Instead of biological 
substrates, Ishida et al. used glass plates as model substrate 
by shearing stickiness apparatus and Gurney et al. used 
polymethyl methacrylate to study shear stress of carbapol 
and sodium CMC by Instron model 1114, respectively 86. 
Determination of tensile strength 
Tensile stress is also termed Maximum Stress or Ultimate Tensile 
Stress. The resistance of a material to a force tending to tear it 
apart, measured as the maximum tension the material can 
withstand without tearing. Tensile strength can be defined as 
the strength of material expressed as the greatest longitudinal 
stress it can bear without tearing apart. As it is the maximum 
load applied in breaking a tensile test piece divided by the 
original cross-sectional area of the test piece, it is measured as 
Newtons/sq.m. Specifically, the tensile strength of a material is 
the maximum amount of tensile stress that it can be subjected 
to before failure. The definition of failure can vary according to 
material type and design methodology87. 
There are three typical definitions of tensile strength88: 
Yield Strength- The stress a material can withstand without 
permanent deformation. 
Ultimate Strength-  The maximum stress a material can 
withstand. 
Breaking Strength-  The stress coordinate on the stress– 
strain curve at the point of rupture. 
Methods using the tensile strength usually measure the force 
required to break the adhesive bond between a model 
membrane and the test polymers. 
Lehr et al. determined tensile strength of flat-faced buccal 
adhesive tablets, with a diameter of 5.5 mm containing 50 mg 
of the mucoadhesive material is to be tested for its shear 
stresses by clamping the model mucosal surface between 
two plates, one having a U-shaped section cut away to expose 
the test surface. The tablet was attached to a Perspex disc, and 
then placed into contact with the exposed mucosa at the base 
of the U shaped cut. 1.5 g weight was used to consolidate the 
adhesive joint for 2 min, and the plates were oriented from 
horizontal to vertical and Perspex disc attached to the 
underside of the balance, which was linked to a 
microcomputer for data collection. A shear stress was applied 
by lowering the plates and model mucosa at a rate of 2 mm min− 1 
until adhesive joint failure occurred (Figure 4). 
Many researchers studied shear strength of polymers such as 
polyacrylic acid, hydroxy propylcellulose, carbapol 934, 
HPMC etc. using buccal mucosa as substrate by using 
different instruments such as tensile tester, modified pan 
balance etc 89. 
Colloidal gold staining method 
Park proposed the colloidal gold staining technique for the 
study of bioadhesion. The technique employs red colloidal 
gold particles, which were adsorbed on mucin molecules to 
form mucin–gold conjugates, which upon interaction with 
bioadhesive hydrogels develops a red color on the surface. 
This can be quantified by measuring at 525 nm either the 
intensity on the hydrogel surface or the conjugates90. 
Direct staining method 
It is a novel technique to evaluate polymer adhesion to 
human buccal cells following exposure to aqueous polymer 
dispersion, both in vitro and in vivo. Adhering polymer was 
visualized by staining with 0.1% w/ v of either Alcian blue or 
Eosin solution; and the uncomplexed dye was removed by 
washing with 0.25 M sucrose. The extent of polymer adhesion 
was quantified by measuring the relative staining intensity of 
control and polymer treated cells by image analysis. Carbopol 
974 P, polycarbophil and chitosan were found to adhere to 
human buccal cells from 0.10% w/w aqueous dis- persions of 
these polymers. Following in vivo administration as a 
mouthwash, these polymers persisted upon the human 
buccal mucosa for at least one hour. This method is only 
suitable for assessing the liquid dosage forms, which are 
widely employed to enhance oral hygiene and to treat local 
disease conditions of the mouth such as oral candidacies and 
dental caries 91. 
 
 
Figure 4 Schematic representations of apparatus for measuring tensile strength 
 
Qualitative methods 
These methods are useful for preliminary screening of the 
respective polymer for its bio or mucoadhesion, 
compatibility and stability. However, these methods are not 
useful in measuring the actual bioadhesive strength of the 
polymers. They are 92  
Viscometric method  
Katarina Edsman has studied the dynamic rheological 
measurements on gels containing four different carbopol 
polymers and the corresponding mixtures with porcine gastric 
mucin and bovine submaxillary mucin. The method does not 
give the same ranking order when two different comparison 
strategies were used. The results were contrast to the results 
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obtained with the tensile strength measurements. 
Analytical ultracentrifuge criteria for mucoadhesion 
 These methods are useful in identifying the material that is able 
to form complexes with the mucin. The assay can be done for 
change in molecular mass using sedimentation equilibrium, but 
this has an upper limit of less than 50 MDa. Since complexes can be 
very large, a more sensible assay procedure is to use 
sedimentation velocity with change in sedimentation coefficient, 
s, as their marker for mucoadhesion. Where mucin is available 
in only miniscule amounts, a special procedure known as 
Sedimentation Fingerprint- ing can be used for assay of the 
effect on the mucoadhesive. UV absorption optics is used as the 
optical detection system. However, in this case the mucoadhesive 
is invisible, but the pig gastric mucin at the concentrations 
normally employed is visible. The sedimentation ratio 
(scomplex/smucin), the ratio of the sedimentation coef- ficient of any 
complex involving the mucin to that of pure mucin itself, is used 
as the measure for mucoadhesion. 
Atomic force microscopy 
This method is based on the changes in surface topography 
when the polymer bound on to buccal cell surfaces. Unbound 
cells shows relatively smooth surface characteristics with 
many small craters like pits and indentations spread over 
cell surfaces, while polymer bound cells will lose crater and 
indentation characteristics and gained a higher surface 
roughness. 
Electrical conductance 
Bremakar used modified rotational viscometer to determine 
electrical conductance of various semi-solid mucoadhesive 
ointments and found that the electrical conductance was low in 
the presence of adhesive material. 
Fluorescent probe method 
In this method the membrane lipid bilayered and membrane 
proteins were labeled with pyrene and fluorescein 
isothiocyanate, respectively. The cells were mixed with the 
mucoadhesive agents and changes in fluorescence spectra 
were monitored. This gave a direct indication of polymer 
binding and its influence on polymer adhesion. 
Lectin binding inhibition technique 
The method involves an avidinbiotin complex and a 
colorimetric detection system to investigate the binding of 
bioadhesive polymers to buccal epithelial cells without 
having to alter their physicochemical properties by the 
addition of marker entities. The lectin cancanavalian A has 
been shown to specifically bind to sugar groups present on 
the surface of buccal cells. If polymers bind to buccal cells, 
they will mask the surface glycoconjugates, thus reducing or 
inhibiting cancanavalian A binding. 
Thumb test 
This is a very simple test used for the qualitative 
determination of peel adhesive strength of the polymer and 
is useful tool in the development of buccal adhesive delivery 
systems. The adhesiveness is measured by the difficulty of 
pulling the thumb from the adhesive as a function of the 
pressure and the contact time. Although the thumb test may 
not be conclusive, it provides useful information on peel 
strength of the polymer. 
Factors affecting bio/mucoadhesion 
Numerous studies have indicated that there is certain 
molecular weight at which bioadhesion is optimum. The 
optimum molecular weight for the maximum bioadhesion 
depends on the type of polymers. It dictates the degree of 
swelling in water, which in turn determines interpenetration of 
polymer molecules within the mucus. It seems that the 
bioadhesive force increases with the molecular weight up to 
100,000 and beyond this level there is not much effect. For the 
best bioadhesion to occur, the con- centration of polymer 
must be at optimum. Flexibility of polymer chain is also 
important for interpenetration and entanglement. As water-
soluble polymers become cross-linked, the mobility of the 
individual polymer chain decreases. As the cross linking 
density increases, the effective length of the chain, which can 
penetrate into the mucus layer, decreases even further and 
mucoadhesive strength is reduced. Besides molecular weight 
or chain length, spatial conformation of a molecule is also 
important. Despite a high molecular weight of 19,500,000 for 
dextrans, they have similar adhesive strength to that of 
polyethylene glycol with a molecular weight of 200,000. The 
helical conformation of dextran may shield many adhesively 
active groups, primarily responsible for adhesion, unlike PEG 
polymers, which have a linear conformation. Swelling is not 
only related to the polymer itself, and also to its environment. 
Interpenetration of chains is easier as polymer chains are 
disentangled and free of interactions. Swelling depends both 
on polymer concentration and the presence of water. When 
swelling is too great, a decrease in bioadhesion occurs 93. 
IV. DEVELOPMENTS IN BUCCAL ADHESIVE 
DRUG DELIVERY 
Retentive buccal mucoadhesive formulations may prove to be 
an alternative to the conventional oral medications as they can 
be readily attached to the buccal cavity retained for a longer 
period of time and removed at any time. Buccal adhesive drug 
delivery systems using matrix tablets, films, layered systems, 
discs, micro spheres, ointments and hydrogel systems has been 
studied and reported by several research groups. However, 
limited studies exist on novel devices that are superior to those 
of conventional buccal adhesive systems for the delivery of 
therapeutic agents through buccal mucosa. A number of 
formulation and processing factors can influence properties 
and release properties of the buccal ad- hesive system. There 
are numerous important considerations that include 
biocompatibility (both the drug/device and device/ 
environment interfaces), reliability, durability; environmental 
sta- bility, accuracy, delivery scalability and permeability are to 
be considered while developing such formulations. While 
biocom patibility is always an important consideration, other 
considerations vary in importance depending on the device 
application. Bioadhesive formulations designed for buccal 
application should exhibit suitable rheological and mechanical 
properties, including pseudo- plastic or plastic flow with 
thixotrophy, ease of application, good spreadability, appropriate 
hardness, and prolonged residence time in the oral cavity. These 
properties may affect the ultimate perfor- mance of the 
preparations and their acceptance by patients94. 
Research on buccal adhesive drug delivery systems  
Several buccal adhesive delivery devices were developed at 
the laboratory scale by many researchers either for local or 
systemic actions. They are broadly classified in to Solid 
buccal adhesive dosage forms, Semi-solid buccal adhesive 
dosage forms and Liquid buccal adhesive dosage forms 95 . 
V. EVALUATION 
In addition to the routine evaluation tests such as weight 
variation, friability, hardness, content uniformity, in vitro 
dissolution for tablets; tensile strength, film endurance, 
hygroscopicity etc for films and patches; viscosity, effect of 
aging etc for gels and ointments; buccal adhesive drug 
delivery devices are also to be evaluated specifically for their 
mucoadhesive strength and permeability. 
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Determination of the residence time 96 
In vitro residence time 
It was determined using a modified USP disintegration 
apparatus as shown in Figure 5. The disintegration medium 
composed of 800 ml isotonic phosphate buffer pH 6.75 
maintained at 37 °C. A segment of rabbit intestinal mucosa, 3 
cm long, was glued to the surface of a glass slab, vertically 
attached to the apparatus. The mucoadhesive tablet was 
hydrated from one surface using 15 ml IPB and then the 
hydrated surface was brought into contact with the mucosal 
membrane. The glass slab was vertically fixed to the 
apparatus and allowed to move up and down so that the 
tablet was completely immersed in the buffer solution at the 
lowest point and was out at the highest point. The time 
necessary for complete erosion or detachment of the tablet 
from the mucosal surface was recorded. 
In vivo residence time test 
The experiment was conducted on four human healthy 
volunteers of 25–50 years old. Plain bioadhesive tablets with 
optimized properties were selected for the in vivo. The 
bioadhesive tablet was placed on the buccal mucosa between 
the cheek and gingiva in the region of the upper canine and 
gently pressed onto the mucosa for about 30 s. The tablet 
and the inner upper lip were carefully moistened with saliva 
to prevent the sticking of the tablet to the lip. The volunteers 
were asked to monitor the easewith which the system was 
retained on themucosa and note any tendency for 
detachment. The time necessary for complete erosion of the 
tablet was simultaneously monitored by carefully observing 
for residual polymer on the mucosa. In addition, any 
complaints such as discomfort, bad taste, dry mouth or 
increase of salivary flux, difficulty in speaking, irritation or 
mucosal lesions were carefully recorded. Repeated 
application of the bioadhesive tablets was allowed after a 
two days period for the same volunteer. 
Permeation studies 
During the preformulation studies, buccal absorption/ 
permeation studies must be conducted to determine the 
feasibility of this route of administration for the candidate 
drug and to determine the type of enhancer and its 
concentration required to control the rate of permeation of 
drugs. These studies involvemethods that would examine in 
vitro, ex vivo and/or in vivo buccal permeation profile and 
absorption kinetics of the drug. 
In vitro methods 97 
Deasy  used an apparatus consisting of a water jacket and an 
internal compartment containing 50 ml of simulated saliva 
as dissolution medium to study the release of 
cetylpyridinium chloride tablet by placing in the metal die 
sealed at the lower end by paraffin wax to ensure the drug 
release from one end alone. The medium was stirred with a 
rotating stirrer at 250 rpm. Ishida conducted dissolution 
studies with similar apparatus with slight modification of 
providing a water jacket for the maintenance of temperature 
for dosage forms of lidocaine. Nagai used Toyamp-Sangyo 
TR-553 dissolution tester to measure the dissolution rate of 
disk like dosage forms by keeping in a rotating basket at 100 
rpm in 900 ml of purified water. The same apparatus was 
used for the evaluation of oral mucosal dosage forms of 
insulin. Hughes and Gehris described a novel dissolution 
testing system that is capable of characterizing buccal 
dissolution. 
It comprises of a single, stirred, continuous flow-through 
filtration cell that includes a dip tube designed to remove 
finely divided solid particles. Filtered solution is removed 
continuously and used to analyze for dissolved drug. 
 
 
Figure 5 Schematic diagram of the apparatus used for the determination of residence time. S: glass slab; D: disintegration 
apparatus; B: glass beaker; M: mucosal membrane; T: mucoadhesive tablet; IBP: Isotonic phosphate buffer. 
Ex vivo methods 98 
Most of the ex vivo studies examining drug transport across 
buccal mucosa uses buccal tissues from animal models. 
Immediately after sacrificing the animals the buccal mucosal 
tissue is surgically removed from the oral cavity. The 
membranes are stored in Krebs buffer at 4 °C until mounted 
in the diffusion cells for the ex vivo permeation experiments. 
Preservation of the dissected tissue is an important issue 
that will affect the studies. 
There is no standard means by which the viability or the 
integrity of the dissected tissue can be assessed. The most 
meaningful method to assess tissue viability is the actual 
permeation experiment itself, if the drug permeability does 
not change during the time course of the study under the 
specific experimental conditions of pH and temperature, 
then the tissue is considered viable. 
Dowty] studied tissue viability by using ATP levels in rabbit 
buccal mucosa. He reported a 50% drop in the tissue ATP 
concentration during the initial 6 h of the experiment 
without a corresponding drop in tissue permeability. Despite 
certain gradual changes, the buccal tissue seems to remain 
viable for a rather long period of time. Hence, a decrease in 
ATP levels does not assure a drop in permeability 
characteristics of the tissue. 
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Buccal cell cultures have also been suggested as useful in 
vitro models for buccal drug permeation and metabolism. 
However, to utilize these culture cells for buccal drug 
transport, the number of differentiated cell layers and the 
lipid composition of the barrier layers must be well 
characterized and controlled. 
 In vivo methods 99 
Selection of animal species 
 Apart from the specific methodology used to study buccal 
drug permeation characteristics, special attention is 
warranted to the selection of experimental animal species 
for such experiments. Many researchers have used small 
animals including rats and hamsters for permeability 
studies. But unlike humans, most laboratory animals have 
totally keratinized oral lining, hence not suitable. The rat has 
a buccal mucosa with a very thick, keratinized surface layer. 
The rabbit is the only laboratory rodent that has non-
keratinized mucosal lining similar to human tissue. But, the 
sudden transition to keratinized tissue at the mucosal 
margins makes it hard to isolate the desired non-keratinized 
region. 
Buccal absorption test. 
Beckett and Triggs developed a method to measure the 
kinetics of drug absorption. It is carried out by swirling of a 
25 ml sample of the test solution for 15 min by human 
volunteers followed by the expulsion of the solution. The 
amount of drug remaining in the expelled volume is then 
determined to assess the amount of drug absorbed. The 
drawbacks of this method are inability to localize the drug 
solution within a specific site of the oral cavity, accidental 
swallowing of a portion of the sample solution and the 
salivary dilution of the drug. 
Modified buccal absorption test 
Gonzalez-Younes et al. developed this method by correcting 
for salivary dilution and accidental swallowing, but these 
modifications also suffer from the inability of site 
localization. 
Perfusion system 
 A circulating perfusion chamber attached to the upper lip of 
anesthetized dogs by cyanoacrylate cement and the drug 
solution is circulated through the device for a predetermined 
period of time. Sample fractions are collected from the 
perfusion chamber and blood samples are drawn at regular 
intervals. 
Buccal perfusion cell apparatus 100 
Rathbone developed an apparatus that provides continuous 
monitoring of drug loss as a function of time offers larger 
area for drug transfer and has no leakage problem. He used 
several methods to study the rate and extent of drug loss 
from human oral cavity. These include the buccal absorption 
test, disk methods and perfusion cells. These methods have 
provided information on the mechanism by which drugs are 
transported across oral cavity membranes and suggest that 
passive diffusion or carrier mediated transport systems may 
be involved. In vivo buccal permeation of FITC labeled 
dextran 4400 and the peptide drug buserelin was 
investigated in pigs. The delivery device consisted of an 
application chamber with a solution of FD4 or buserelin, and 
was attached to the buccal mucosa for four hours using an 
adhesive patch. The randomized crossover study including 
intravenous administration and buccal delivery without and 
with 10 mM sodium glycodeoxycholate as an absorption 
enhancer was performed in pigs. 
VI. CONCLUSION 
For research it is the need to drug delivery systems extends 
beyond ways to administer new pharmaceutical therapies. 
The safety and efficacy of current treatments may be 
improved if their delivery rates, biodegradation and site 
specific targeting can be predicted, monitored and 
controlled. Buccal adhesive systems offer innumerable 
advantages in terms of accessibility, administration and 
withdrawal, retentivity, low enzymatic activity, economy 
and high patient compliance. Since the introduction of 
Orabase in 1947, when gum tragacanth was mixed with 
dental adhesive powder to apply penicillin to the oral 
mucosa; the market share of bioadhesive drug delivery 
systems is increasing.  In addition, buccal adhesive dosage 
forms have been used to target local disorders at the 
mucosal surface (e.g., mouth ulcers) to reduce the overall 
dosage required and minimize side effects that may be 
caused by systemic administration of drugs. Researchers are 
now looking beyond traditional polymer networks to find 
other innovative drug transport systems.  
At the current global scenario, scientists are finding ways to 
develop buccal adhesive systems through various 
approaches to improve the bioavailability of orally poor 
soluble drugs by manipulating the formulation strategies 
like inclusion of pH modifiers, enzyme inhibitors, 
permeation enhances etc. Novel buccal adhesive delivery 
system, where the drug delivery is directed towards buccal 
mucosa by protecting the local environment is also gaining 
interest. Currently solid dosage forms, liquids and gels 
applied to oral cavity are commercially successful. The 
future direction of buccal adhesive drug delivery lies in 
vaccine formulations and delivery of small 
proteins/peptides. Microparticulate bioadhesive systems are 
particularly interesting as they offer protection to 
therapeutic entities as well as the enhanced absorption that 
result from increased contact time provided by the 
bioadhesive component.  
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